Skip to main content
. 2025 Feb 11;9(2):102702. doi: 10.1016/j.rpth.2025.102702

Table 2.

The treatment costs for 12 months in the different groups (USD/kg/y).

Item Stepwise group n = 86 TPO-RA group (monotherapy) n = 12 TPO-RA group (combination therapies) n = 18
Cost of medicines, median (range) 0.05 (0.01-1399.25) 395.11 (88.81-1233.44) 357.04 (90.40-1090.65)
Cost of rescue therapies, median (range) 17.07 (0-136.45) 0 (0-34.11) 17.05 (0-68.27)
Total cost, median (range) 68.26 (0.01-1415.30) 395.11 (100.88-1267.57) 373.85 (107.39-1106.94)

Due to the loss of follow-up, the treatment cost data at 12 months included 86 cases in the stepwise group and 18 cases in the TPO-RA group (combination therapy).

TPO-RA, thrombopoietin receptor agonist.